Atherosclerosis is a high-cost disease and its complications still represent the first cause of
death in most industrialized countries. Efficacious prevention includes treatment of the most …

Background In aging, a host of molecular and cellular changes occur which accelerate
alteration and progression of inflammatory diseases. These conditions in the elderly people …

Atherosclerosis is a well-known global health problem. Despite the high prevalence of the
disease, numerous aspects of pathogenesis remain unclear. Subsequently, there are still no …

Atherogenesis has been traditionally viewed as a metabolic disease representing arterial
obstruction by fatty deposits in its wall. Today, it is believed that atherogenesis involves …

This work was designed to study direct anticytokine activity of natural products on the cell
model of inflammation. We developed a combination of medicinal plants (calendula, elder …

Atherosclerosis is the most common cardiovascular disease and is the number one cause of
death worldwide. Today, atherosclerosis is a multifactorial chronic inflammatory disease with …

Introduction: Preservation of vascular endothelium integrity and maintenance of its full
functionality are fundamental aspects in order to avoid both cardiovascular and non …

Background: Cardiovascular disease (CVD) remains the leading cause of global death, with
atherosclerosis being a major contributor to this mortality. Several mechanisms are …

Antithrombotic therapy is the cornerstone of the treatment of acute coronary syndromes, but
there is now evidence which indicates that by blocking inflammation, thrombosis and thus …

The experimental and clinical data concerning pathogenesis of the atherosclerosis are
summarized and analyzed in this article. Major concepts that explain initiation and …